Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
about
Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling.Opposing effects of prostaglandin E2 receptors EP3 and EP4 on mouse and human β-cell survival and proliferationEnriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E2 Signaling and Enhances Diabetic β-Cell Function.Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain-Adipocyte Axis.The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice.Exendin-4 promotes the osteogenic differentiation of osteoblasts via the Hedgehog/Gli1 signaling pathway.Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus.
P2860
Q33714751-E8E2AA42-E2B6-49AA-BE7F-82CE4017DAD2Q33726561-92B27157-4CC8-486F-8A2B-7619807EA1DBQ38289067-4969C0F4-D641-48F2-9D3A-3CF885A45030Q38753804-E66A547D-7DE4-4033-80DB-2A994A324ED7Q47913426-20446763-B238-4D65-95B2-D1AF7F5789EBQ49371368-0E89D944-647B-43BA-BE22-C972A2140A1EQ52674501-E813DE47-B2E3-492F-83C1-21A81E626C27
P2860
Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Synergy Between Gαz Deficiency ...... Mass in Experimental Diabetes.
@en
type
label
Synergy Between Gαz Deficiency ...... Mass in Experimental Diabetes.
@en
prefLabel
Synergy Between Gαz Deficiency ...... Mass in Experimental Diabetes.
@en
P2093
P2860
P356
P1476
Synergy Between Gαz Deficiency ...... Mass in Experimental Diabetes
@en
P2093
Harpreet K Brar
Jaclyn A Wisinski
Mark T Cadena
Mary F Thompson
Michael D Schaid
Michelle E Kimple
Renee L Pasker
P2860
P304
P356
10.1210/ME.2015-1164
P577
2016-04-06T00:00:00Z